{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T11:09:36Z","timestamp":1775646576076,"version":"3.50.1"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2016,10,17]],"date-time":"2016-10-17T00:00:00Z","timestamp":1476662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1R01AI081062"],"award-info":[{"award-number":["1R01AI081062"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"China Scholarship Council PhD exchange program","award":["201406050119"],"award-info":[{"award-number":["201406050119"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0164792","type":"journal-article","created":{"date-parts":[[2016,10,17]],"date-time":"2016-10-17T13:27:42Z","timestamp":1476710862000},"page":"e0164792","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Differential Adverse Event Profiles Associated with BCG as a Preventive Tuberculosis Vaccine or Therapeutic Bladder Cancer Vaccine Identified by Comparative Ontology-Based VAERS and Literature Meta-Analysis"],"prefix":"10.1371","volume":"11","author":[{"given":"Jiangan","family":"Xie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Codd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongqun","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,10,17]]},"reference":[{"issue":"1","key":"ref1","first-page":"53","article-title":"History of BCG Vaccine","volume":"8","author":"S Luca","year":"2013","journal-title":"Maedica"},{"issue":"8","key":"ref2","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrmicro1211","article-title":"The success and failure of BCG\u2014implications for a novel tuberculosis vaccine","volume":"3","author":"P Andersen","year":"2005","journal-title":"Nature reviews Microbiology"},{"key":"ref3","article-title":"Weekly epidemiological record: relev\u00e9 \u00e9pid\u00e9miologique hebdomadaire","year":"2006"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1445-2197.1998.tb04768.x","article-title":"Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: review of complications and their treatment","volume":"68","author":"DL Paterson","year":"1998","journal-title":"The Australian and New Zealand journal of surgery"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.juro.2007.08.122","article-title":"History of bacillus Calmette-Guerin and bladder cancer: An immunotherapy success story","volume":"179","author":"HW Herr","year":"2008","journal-title":"J Urology"},{"key":"ref6","first-page":"97","article-title":"Cancer and tuberculosis","volume":"9","author":"R Pearl","year":"1929","journal-title":"Am J Hygiene"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1086\/338462","article-title":"National study of adverse reactions after vaccination with bacille Calmette-Gu\u00e9rin","volume":"34","author":"F Turnbull","year":"2002","journal-title":"Clinical infectious diseases"},{"issue":"11","key":"ref8","first-page":"809","article-title":"Severe adverse reactions after vaccination with Japanese BCG vaccine: a review","volume":"82","author":"I Toida","year":"2007","journal-title":"Kekkaku: Tuberculosis"},{"key":"ref9","unstructured":"FDA. What is a Serious Adverse Event? Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.fda.gov\/Safety\/MedWatch\/HowToReport\/ucm053087.htm\" xlink:type=\"simple\">http:\/\/www.fda.gov\/Safety\/MedWatch\/HowToReport\/ucm053087.htm<\/ext-link> (Accessed: 5th October 2016)."},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/0264-410X(94)90315-8","article-title":"The vaccine adverse event reporting system (VAERS)","volume":"12","author":"RT Chen","year":"1994","journal-title":"Vaccine"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2165\/00002018-200629050-00002","article-title":"Data mining in the US using the vaccine adverse event reporting system","volume":"29","author":"J Iskander","year":"2006","journal-title":"Drug safety"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2165\/00002018-199920020-00002","article-title":"The medical dictionary for regulatory activities (MedDRA)","volume":"20","author":"EG Brown","year":"1999","journal-title":"Drug safety"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2165\/00002018-200326030-00002","article-title":"Methods and pitfalls in searching drug safety databases utilising the Medical Dictionary for Regulatory Activities (MedDRA)","volume":"26","author":"EG Brown","year":"2003","journal-title":"Drug safety"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/2041-1480-5-29","article-title":"OAE: The Ontology of Adverse Events","volume":"5","author":"YQ He","year":"2014","journal-title":"J Biomed Semant"},{"issue":"11","key":"ref15","doi-asserted-by":"crossref","first-page":"e49941","DOI":"10.1371\/journal.pone.0049941","article-title":"Ontology-Based Combinatorial Comparative Analysis of Adverse Events Associated with Killed and Live Influenza Vaccines","volume":"7","author":"S Sarntivijai","year":"2012","journal-title":"Plos One"},{"key":"ref16","first-page":"1","article-title":"Linking MedDRA<sup>\u00ae<\/sup>-Coded Clinical Phenotypes to Biological Mechanisms by the Ontology of Adverse Events: A Pilot Study on Tyrosine Kinase Inhibitors","author":"S Sarntivijai","year":"2016","journal-title":"Drug safety"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s40495-016-0055-0","article-title":"Ontology-based vaccine and drug adverse event representation and theory-guided systematic causal network analysis toward integrative pharmacovigilance research","volume":"2","author":"Y He","year":"2016","journal-title":"Current Pharmacology Reports"},{"issue":"6","key":"ref18","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/pds.677","article-title":"Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports","volume":"10","author":"SJW Evans","year":"2001","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2307\/2983604","article-title":"Contingency tables involving small numbers and the \u03c7<sup>2<\/sup> test","volume":"1","author":"F Yates","year":"1934","journal-title":"Supplement to the Journal of the Royal Statistical Society"},{"issue":"9","key":"ref20","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/pds.1107","article-title":"Comparing data mining methods on the VAERS database","volume":"14","author":"D Banks","year":"2005","journal-title":"Pharmacoepidem Dr S"},{"issue":"Suppl 1","key":"ref21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s10278-007-9065-0","article-title":"Protege: a tool for managing and using terminology in radiology applications","volume":"20","author":"DL Rubin","year":"2007","journal-title":"Journal of digital imaging"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/1756-0500-3-175","article-title":"OntoFox: web-based support for ontology reuse","volume":"3","author":"Z Xiang","year":"2010","journal-title":"BMC research notes"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"D Moher","year":"2015","journal-title":"Systematic reviews"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"W","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"151","author":"A Liberati","year":"2009","journal-title":"Annals of internal medicine"},{"issue":"7","key":"ref25","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1586\/14760584.2014.923762","article-title":"Ontology-supported research on vaccine efficacy, safety and integrative biological networks","volume":"13","author":"Y He","year":"2014","journal-title":"Expert review of vaccines"},{"key":"ref26","unstructured":"Smith B. Invited Papers from the 10th International Conference in Logic Methodology and Philosophy of Science, Oviedo, Spain [Internet]2003."},{"key":"ref27","unstructured":"FDA. BCG vaccine for percutaneous use\u2014U.S. Food and Drug Administration. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM202934.pdf\" xlink:type=\"simple\">http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM202934.pdf<\/ext-link> (Aceessed 5 October 2016)."},{"key":"ref28","unstructured":"FDA. BCG live for intravesical use\u2014U.S. Food and Drug Administration. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM163039.pdf\" xlink:type=\"simple\">http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM163039.pdf<\/ext-link> (Aceessed 5 October 2016)."},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s40264-014-0248-6","article-title":"Bacillus Calmette-Guerin (BCG) vaccine adverse events in Victoria, Australia: analysis of reports to an enhanced passive surveillance system","volume":"38","author":"HJ Clothier","year":"2015","journal-title":"Drug safety"},{"issue":"4","key":"ref30","first-page":"399","article-title":"Rates of adverse reactions to first and second doses of BCG vaccination: results of a large community trial in Brazilian schoolchildren","volume":"7","author":"I Dourado","year":"2003","journal-title":"The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease"},{"issue":"6","key":"ref31","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.puhe.2015.03.003","article-title":"Surveillance of adverse events following vaccination in the French armed forces, 2011\u20132012","volume":"129","author":"A Mayet","year":"2015","journal-title":"Public health"},{"issue":"7","key":"ref32","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/adc.2005.078972","article-title":"Complications associated with the bacille Calmette-Guerin vaccination in Ireland","volume":"91","author":"T Bolger","year":"2006","journal-title":"Archives of disease in childhood"},{"issue":"39","key":"ref33","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.1016\/j.vaccine.2014.07.020","article-title":"Active surveillance of adverse events following childhood immunization in Singapore","volume":"32","author":"KC Thoon","year":"2014","journal-title":"Vaccine"},{"issue":"6","key":"ref34","first-page":"491","article-title":"Literature review of adverse events following immunization of Bacillus Calemtte-Guerin vaccine","volume":"15","author":"WD Wu","year":"2009","journal-title":"Zhongguo yi miao he mian yi"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2223\/JPED.1146","article-title":"Percutaneous or intradermal BCG vaccine?","volume":"80","author":"LF Bricks","year":"2004","journal-title":"Jornal de pediatria"},{"issue":"4","key":"ref36","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/499825","article-title":"The effect of bacille Calmette-Guerin vaccine strain and route of administration on induced immune responses in vaccinated infants","volume":"193","author":"V Davids","year":"2006","journal-title":"Journal of Infectious Diseases"},{"issue":"3","key":"ref37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrurol.2014.15","article-title":"The mechanism of action of BCG therapy for bladder cancer\u2014a current perspective","volume":"11","author":"G Redelman-Sidi","year":"2014","journal-title":"Nature reviews Urology"},{"issue":"22","key":"ref38","first-page":"687","article-title":"Addition of severe combined immunodeficiency as a contraindication for administration of rotavirus vaccine","volume":"59","year":"2010","journal-title":"MMWR Morbidity and mortality weekly report"},{"key":"ref39","article-title":"Advances in Patient Safety: From Research to Implementation (Volume 2: Concepts and Methodology). Advances in Patient Safety","author":"KS Kohl","year":"2005"},{"issue":"22","key":"ref40","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1016\/S0264-410X(99)00132-2","article-title":"An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system. VAERS Working Group","volume":"17","author":"JA Singleton","year":"1999","journal-title":"Vaccine"},{"key":"ref41","first-page":"218590","article-title":"Emerging vaccine informatics","volume":"2010","author":"Y He","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"ref42","first-page":"101","article-title":"SNOMED CT: utility for a general medical evaluation template","volume":"2006","author":"SH Brown","journal-title":"AMIA Annu Symp Proc"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0164792","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T01:46:57Z","timestamp":1540259217000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0164792"}},"subtitle":[],"editor":[{"given":"Anil Kumar","family":"Tyagi","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,10,17]]},"references-count":42,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,10,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0164792","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,17]]}}}